Initiating HIV therapy. Timing is critical, controversial.

about

Disease Management - Constructing Optimal NRTI-Based Combinations: Past, Present, and Future.

P2860

Q37381677-F52225A2-7C55-4D09-9749-62FBE4167AAC

P2860

Initiating HIV therapy. Timing is critical, controversial.

Item

http://www.wikidata.org/entity/Q35682050

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Initiating HIV therapy. Timing is critical, controversial.

@ast

Initiating HIV therapy. Timing is critical, controversial.

@en

type

Item

label

Initiating HIV therapy. Timing is critical, controversial.

@ast

Initiating HIV therapy. Timing is critical, controversial.

@en

prefLabel

Initiating HIV therapy. Timing is critical, controversial.

@ast

Initiating HIV therapy. Timing is critical, controversial.

@en

P1476

Initiating HIV therapy. Timing is critical, controversial.

@en

P2093

Paul A Volberding

http://www.w3.org/2001/XMLSchema#string

P2860

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.

Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy.

Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.

HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy.

Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions.

Cytomegalovirus (CMV)-specific CD4+ T lymphocyte immune function in long-term survivors of AIDS-related CMV end-organ disease who are receiving potent antiretroviral therapy.

Evidence of immune reconstitution in antiretroviral drug-experienced patients with advanced HIV disease.

Virologic and immunologic values allowing safe deferral of antiretroviral therapy.

Multiple relapses of human cytomegalovirus retinitis during HAART in an AIDS patient with reconstitution of CD4+ T cell count in the absence of HCMV-specific CD4+ T cell response.

P304

15-8, 21, 24-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3810/PGM.2004.02.1441

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P577

2004-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15000057

http://www.w3.org/2001/XMLSchema#string

Initiating HIV therapy. Timing is critical, controversial.

about

P2860

P2860

Initiating HIV therapy. Timing is critical, controversial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698